Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency

Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency

Stephen Jolles Department of Immunology, University Hospital of Wales, Cardiff, UK Abstract: Immunoglobulin (Ig)-replacement therapy represents the mainstay of treatment for patients with primary antibody deficiency and is administered either intravenously (IVIg) or subcutaneously (SCIg). While hya...

Full description

Bibliographic Details
Main Author: Jolles S
Format: Article
Language:English
Published: Dove Medical Press 2013-09-01
Series:ImmunoTargets and Therapy
Subjects:
Enzyme-facilitated IgG infusion
IGHy
hyaluronan
recombinant human Hyaluronidase
rhuPH20
subcutaneous immunoglobulin therapy
primary immunodeficiency disease
subcutaneous immunoglobulin SCIg
intravenous immunoglobulin IVIg
Online Access:https://www.dovepress.com/hyaluronidase-facilitated-subcutaneous-immunoglobulin-in-primary-immun-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/hyaluronidase-facilitated-subcutaneous-immunoglobulin-in-primary-immun-peer-reviewed-article-ITT

Similar Items